OPTIMIZATION OF ANTI-EDEMA THERAPY IN SEVERE TRAUMATIC BRAIN INJURY

Authors

  • Ashurov T.Kh

Keywords:

traumatic brain injury, neuroinflammation, cerebral edema, paracetamol, Glasgow coma scale, intracranial hypertension

Abstract

Neuroinflammation and cerebral edema are central mechanisms in the pathophysiology of severe traumatic brain injury (TBI). This study evaluated the effectiveness of adding Paracetamol infusion to standard therapy in patients with severe TBI. A total of 40 patients were enrolled, divided into control and main groups. In the main group, significant reductions in pro-inflammatory cytokines (IL-1β, IL-6, TNF-α) and an increase in the anti-inflammatory cytokine IL-10 were observed, alongside improvements in Glasgow Coma Scale scores and reduced cerebral edema volume on CT scans. The multimodal approach incorporating Paracetamol infusion demonstrated promising potential for controlling neuroinflammation and accelerating recovery in severe TBI patients.

References

Albert-Weissenberger C, Sirén AL. Experimental traumatic brain injury. Exp Transl Stroke Med. 2016;8(1):16. doi:10.1186/s13231-016-0028-3

Carney N, Totten AM, O'Reilly C, et al. Guidelines for the management of severe traumatic brain injury, fourth edition. Neurosurgery. 2017;80(1):6-15. doi:10.1227/NEU.0000000000001432

Centers for Disease Control and Prevention. Report to Congress on Traumatic Brain Injury in the United States: Epidemiology and Rehabilitation. CDC; 2021.

Dewan MC, Rattani A, Gupta S, et al. Estimating the global incidence of traumatic brain injury. J Neurosurg. 2018;130(4):1080-1097. doi:10.3171/2017.10.JNS17352

Graham GG, Scott KF. Mechanism of action of paracetamol. Am J Ther. 2005;12(1):46-55. doi:10.1097/00045391-200501000-00008

Jha RM, Kochanek PM, Simard JM. Pathophysiology and treatment of cerebral edema in traumatic brain injury. Neuropharmacology. 2019;145(Pt B):230-246. doi:10.1016/j.neuropharm.2018.09.008

Loane DJ, Kumar A. Microglia in the TBI brain: The good, the bad, and the dysregulated. Exp Neurol. 2016;275(Pt 3):316-327. doi:10.1016/j.expneurol.2015.08.018

Maas AIR, Menon DK, Adelson PD, et al. Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research. Lancet Neurol. 2017;16(12):987-1048. doi:10.1016/S1474-4422(17)30371-X

Simon DW, McGeachy MJ, Bayır H, Clark RS, Loane DJ, Kochanek PM. The far-reaching scope of neuroinflammation after traumatic brain injury. Nat Rev Neurol. 2017;13(3):171-191. doi:10.1038/nrneurol.2017.13

Sinclair AJ, Ball AK, Burdon MA, et al. Exploring the pathogenesis of IIH: an inflammatory perspective. J Neuroimmunol. 2016;297:69-77. doi:10.1016/j.jneuroim.2016.05.003

Woodcock T, Morganti-Kossmann MC. The role of markers of inflammation in traumatic brain injury. Front Neurol. 2013;4:18. doi:10.3389/fneur.2013.00018

Published

2025-08-12